Highest-materiality recent filing
AleAnna Q2 2026 net income $3.8M, Adjusted EBITDA $4.1M, up from $0.6M/$0.8M YoY
Net income $3.8M and Adjusted EBITDA $4.1M for Q2 2026, vs $0.6M and $0.8M in Q2 2025.
AleAnna reports Q1 net income of $3.4M, Adjusted EBITDA $4.3M; Proved Reserves up 47%
Revenue of $8.9M from Longanesi field; net income of $3.4M.
AleAnna Q4 net income $0.3M, Adj. EBITDA $3.0M; FY net income $2.9M, revenue from Longanesi $9.1M
Full year 2025 net income of $2.9M, Adjusted EBITDA of $6.6M; third consecutive quarter of positive earnings.
AleAnna reports 47% increase in year-end 2025 proved reserves to 25.8 Bcf
Total Proved Reserves of 25.8 Bcf as of Dec 31, 2025, up 47% vs year-end 2024 after subtracting 2025 production.
AleAnna receives production concession for Gradizza Field; expects first gas in Q1 2027
Italian MASE granted 20-year production concession for Gradizza Field, AleAnna's first wholly-owned development.
AleAnna reports Q3 net income of $5.3M; Longanesi field revenue $10.6M
Net income $5.3M ($0.08 EPS), second consecutive profitable quarter; EBITDA $6.3M.
AleAnna announces CFO transition: Yopp resigns, Ronald appointed effective Sept 1, 2025
CFO Tristan Yopp resigns effective September 1, 2025; will depart company.
AleAnna reports FY2024 results; Longanesi gas production commenced March 13, 2025
Completed de-SPAC and began trading on Nasdaq Dec 13, 2024 under ticker ANNA.
Closed on Dec 13, 2024: Swiftmerge acquired AleAnna Energy; combined entity renamed AleAnna, Inc.
Swiftmerge shareholders approve AleAnna Energy merger; ~$13M redeemed
Business combination with AleAnna Energy approved: 5,960,661 for, 2,080 against.
Amended merger agreement eliminates Tax Receivable Agreement as a deliverable; related definitions removed.
Swiftmerge enters merger with AleAnna Energy; consideration of 65M shares
Aggregate merger consideration of 65,098,476 shares of Surviving PubCo common stock.
Shareholders approved extension of business combination deadline from March 15, 2024 to June 17, 2025.
Sponsor assigns economic interest in 3 Founder Shares per 10 Non-Redeemed Shares to unaffiliated investors.
Swiftmerge enters non-redemption pacts to extend SPAC deadline to June 17, 2025
Trust account value per public share was ~$10.92 on March 11, 2024.
Swiftmerge Acquisition Corp. terminates merger with HDL Therapeutics by mutual agreement
Merger agreement dated August 11, 2023 terminated as of February 14, 2024.
Company determined waived deferred underwriting commissions were improperly classified as liability after waiver obtained in November 2022.
Swiftmerge Acquisition Corp. announces $400M merger with HDL Therapeutics
Swiftmerge (IVCP) to acquire HDL Therapeutics in all-stock/cash deal valued at $400M; $10.00 per share valuation.
Swiftmerge shareholders approve extension to Mar 2024; $210.6M redeemed, trust drops to $23.4M
Shareholders approved extension of business combination deadline from June 17, 2023 to March 15, 2024.
Swiftmerge SPAC gets redemption requests for 20.55M shares; extends reversal deadline to June 19
Received redemption requests for 20,553,090 Class A shares; trust per-share value ~$10.39.
Swiftmerge enters non-redemption agreements for up to 2.1M shares; sponsor to convert founder shares
Non-redemption agreements with unaffiliated investors commit to not redeem up to 2,100,000 Class A ordinary shares.
Swiftmerge receives Nasdaq non-compliance notice for late 2022 10-K filing
Company has 60 days (until June 20, 2023) to submit a plan to regain compliance.
Swiftmerge Acquisition Corp. closes IPO of 20M units at $10.00; $202M placed in trust
IPO of 20,000,000 units at $10.00 per unit raised $200M gross; trust receives $202M including private placement.
Swiftmerge Acquisition Corp. prices $200M IPO at $10/unit; units to trade on Nasdaq
Priced IPO of 20M units at $10/unit; each unit consists of one Class A share and one-half warrant exercisable at $11.50.
On December 14, 2021, General (Ret.) Wesley K. Clark, Brett Conrad, Dr. Leonard Makowka, Dr. Courtney Lyder and Sarah Boatman were appointed as members of the board of directors of the Company
On December 14, 2021, General (Ret.) Wesley K. Clark, Brett Conrad, Dr. Leonard Makowka, Dr. Courtney Lyder and Sarah Boatman were appointed as members of the board of directors of the Company
On December 14, 2021, General (Ret.) Wesley K. Clark, Brett Conrad, Dr. Leonard Makowka, Dr. Courtney Lyder and Sarah Boatman were appointed as members of the board of directors of the Company
On December 14, 2021, General (Ret.) Wesley K. Clark, Brett Conrad, Dr. Leonard Makowka, Dr. Courtney Lyder and Sarah Boatman were appointed as members of the board of directors of the Company
On December 14, 2021, General (Ret.) Wesley K. Clark, Brett Conrad, Dr. Leonard Makowka, Dr. Courtney Lyder and Sarah Boatman were appointed as members of the board of directors of the Company
Max materiality 0.90 · Median 0.65 · Most common event other_material